Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.6 mg vs 1.2 mg with Neostigmine for Neuromuscular Blockade Reversal
NCT02186132Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Mar 2012
- Primary completion
- Feb 2013
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 4 trial of atropine in bradycardia, sponsored by Mahidol University. Started Mar 2012; status: completed.
02
Drugs
atropine
03
Conditions
bradycardia
Beyond the preview
Go deeper on NCT02186132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186132.